Loading clinical trials…
Loading clinical trials…
Clinical trials · failure tracking
Oncology studies whose overall status is TERMINATED, WITHDRAWN or SUSPENDED on ClinicalTrials.gov, with the stop reason exactly as the registrant posted it. A category is attached only when an explicit keyword rule matches the text; CancerIndex never infers why a study stopped.
1,261 stopped studies mapped to Lung Carcinoma and descendants · 91% state a reason
Over the 1,261 studies matching the cancer, status and year filters (the category filter does not change this chart). Each study is counted once, in the first matching category; greyed bars are studies whose text matched no rule or was empty.
Computedrules ci-stop-reasons-v1 · keyword matching only
A category is assigned when one of its keywords appears in the posted text (case-insensitive, whole words). Rules are tested in this order and the first match wins; every match is kept in the API (reasonMatches).
| NCT | Title | Phase | Status | First posted | Lead sponsor | Why stopped (as posted) | Category |
|---|---|---|---|---|---|---|---|
| NCT00161278 | Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC… | Phase 2 | terminated | Sep 12, 2005 | University of Michigan Rogel Cancer Center | recruitment has ended | Enrollment / accrual |
| NCT00535015 | Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small… | Phase 2 | terminated | Sep 26, 2007 | Anaborex | Objectives of study could not be met within a reasonable timeframe. | Other (stated, no rule matched) |
| NCT00607425 | Saliva mRNA Expression Profiling for Early Stage Non-Small Cell Lung Cancer Screening(SPIT-LC) | — | terminated | Feb 5, 2008 | Scottsdale Healthcare | Change in isolation method | Other (stated, no rule matched) |
| NCT00263016 | Docetaxel in Non Small Cell Lung Cancer (NSCLC) | Phase 2 | terminated | Dec 7, 2005 | Sanofi | Slow recruitment | Enrollment / accrual |
| NCT00061646 | Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With… | Phase 2 | terminated | Jun 4, 2003 | Abbott | Enrollment suspended based upon interim analysis; subjects allowed to stay on study until disease… | Efficacy / futility |
| NCT00243204 | Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung… | Phase 3 | terminated | Oct 21, 2005 | Point Therapeutics | FDA Hold May 2007 | Other (stated, no rule matched) |
| NCT00290017 | Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung… | Phase 3 | terminated | Feb 10, 2006 | Point Therapeutics | FDA Hold May 2007 | Other (stated, no rule matched) |
| NCT00316433 | Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer | Phase 2 | terminated | Apr 20, 2006 | Swedish Medical Center | not stated | Not stated |
| NCT00179699 | Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To… | Phase 1 | terminated | Sep 16, 2005 | Celgene Corporation | not stated | Not stated |
| NCT00211952 | Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients | Phase 3 | suspended | Sep 21, 2005 | Medical University of Gdansk | not stated | Not stated |
| NCT00064636 | Phase I Dose Escalation Study of VELCADE Plus Docetaxel in Patients With Advanced… | Phase 1 | terminated | Jul 11, 2003 | Millennium Pharmaceuticals, Inc. | not stated | Not stated |
Stop reasons are registrant-reported free text and are displayed verbatim (truncated; hover for the full text). Categories come from explicit keyword rules and are never inferred from the study design, sponsor or outcome; a study that stopped for several reasons is filed under the first rule that matched. A TERMINATED status does not imply a negative result.
Data updated 22 days agoSource updated Jul 30, 2008source: clinicaltrials